Novel Heterocyclic Compounds for Cancer Chemotherapy

Abstract— Heterocyclic molecules are very important to medical chemistry because they are used to make drugs, especially chemotherapy. The goal of this study is to build on existing manufacturing methods for heterocyclic drugs so that they can be used more effectively in cancer medicine. We want to find new ways to make compounds and get around problems that come up with making complex heterocyclic structures. This will help us find chemicals that are very good at fighting cancer. Biocatalysis and flow chemistry are two current synthetic techniques that we use in our method to speed up the synthesis process, protect the environment, and increase yield and purity. As an environmentally friendly option to standard chemical methods, biocatalysis uses the precision and efficiency of enzymes to speed up processes in mild conditions. Flow chemistry, on the other hand, lets synthesis happen all the time, which makes it easier to direct reactions and make them bigger. For our study, we made a bunch of new heterocyclic chemicals and tested how well they killed different kinds of cancer cells. In early tests, a number of chemicals have shown promise in fighting cancer, showing that they could be used as treatment drugs. Structure-activity relationship (SAR) studies have been done to figure out what about the molecules makes them work, which will help make these chemicals even better. We also used computer chemistry tools to guess how these heterocyclic molecules would react with proteins that play a role in the growth of cancer. These predictions are confirmed by tests done in vitro and in vivo, which give us a full picture of how the drug works and its possible uses in therapy.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-30
DOI
https://doi.org/10.5281/zenodo.14908992
Primary Topic
Innovative Microfluidic and Catalytic Techniques Innovation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Heterocyclic Compounds for Cancer Chemotherapy

Zenodo (CERN European Organization for Nuclear Research)
Innovative Microfluidic and Catalytic Techniques Innovation
article

Novel Heterocyclic Compounds for Cancer Chemotherapy

article en

Abstract

Abstract— Heterocyclic molecules are very important to medical chemistry because they are used to make drugs, especially chemotherapy. The goal of this study is to build on existing manufacturing methods for heterocyclic drugs so that they can be used more effectively in cancer medicine. We want to find new ways to make compounds and get around problems that come up with making complex heterocyclic structures. This will help us find chemicals that are very good at fighting cancer. Biocatalysis and flow chemistry are two current synthetic techniques that we use in our method to speed up the synthesis process, protect the environment, and increase yield and purity. As an environmentally friendly option to standard chemical methods, biocatalysis uses the precision and efficiency of enzymes to speed up processes in mild conditions. Flow chemistry, on the other hand, lets synthesis happen all the time, which makes it easier to direct reactions and make them bigger. For our study, we made a bunch of new heterocyclic chemicals and tested how well they killed different kinds of cancer cells. In early tests, a number of chemicals have shown promise in fighting cancer, showing that they could be used as treatment drugs. Structure-activity relationship (SAR) studies have been done to figure out what about the molecules makes them work, which will help make these chemicals even better. We also used computer chemistry tools to guess how these heterocyclic molecules would react with proteins that play a role in the growth of cancer. These predictions are confirmed by tests done in vitro and in vivo, which give us a full picture of how the drug works and its possible uses in therapy.

Zenodo (CERN European Organization for Nuclear Research)
Life in Land
Openalex Percentile: Top 55%
Innovative Microfluidic and Catalytic Techniques Innovation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.